Navigation Links
Applied Proteomics Appoints William R. LaRue to Board of Directors

SAN DIEGO, July 20, 2015 /PRNewswire/ -- Applied Proteomics Inc., a developer of protein-based molecular diagnostics, announced today the appointment of William R. LaRue to the company's Board of Directors. Mr. LaRue has more than 25 years of experience in corporate leadership and growth strategies, including serving as senior vice president and chief financial officer of Cadence Pharmaceuticals, Inc. from June 2006 through its acquisition by Mallinckrodt plc in 2014 for $1.4 billion.

"The team at Applied Proteomics is pioneering novel and innovative approaches where there is unmet clinical need, particularly in diagnosis of cancer," said Mr. LaRue. "It's an exciting time to come on board, as the team heads toward development and launch of commercial tests."

"Bill's strategic and financial experience make him an ideal addition to our board of directors," said Peter Klemm, Ph.D., president and CEO of Applied Proteomics. "We look forward to benefiting from his deep financial knowledge, particularly in the biotechnology space."

During his eight years as senior vice president and chief financial officer at Cadence Pharmaceuticals, Mr. LaRue helped transition the company from clinical development to commercial operations. Mr. LaRue also serves on the board of directors of TRACON Pharmaceuticals, Inc., focused on targeted therapies for cancer and macular degeneration.

Prior to joining Cadence Pharmaceuticals, Mr. LaRue was senior vice president and chief financial officer for Micromet, Inc. (formerly Cancervax Corporation), a biotechnology company focused on the treatment and control of cancer. Mr. LaRue was vice president and treasurer of Safeskin Corporation, a maker of disposable gloves for the health care, high technology and scientific industries, until its acquisition by Kimberly-Clark Corporation.

Mr. LaRue has an MBA and B.S. in business administration from the University of Southern California.

About Applied Proteomics Inc.

Applied Proteomics Inc. is advancing the application of proteomics to the development of diagnostics, companion diagnostics, and personalized medicine applications to power better medical decisions and care. Applied Proteomics has developed a proteomics platform solution to make protein-based biomarker discovery possible as a replicable, industrial application ready to be applied to health diagnostic problems. Applied Proteomics' platform combines improved instrumentation, faster computing and extensive genome annotations with regimented standard operating procedures, extensive quality controls, and documented processes spanning hundreds of steps from sample collection to processing through informatics. Applied Proteomics is currently advancing a blood-based test for use in helping to assess colorectal cancer . Applied Proteomics is headquartered in San Diego.

For more information, please visit  


SOURCE Applied Proteomics Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Applied Proteomics Appoints Robert C. Verfurth as Vice President, Sales
2. Applied Epidemiologists Call for Antibiotic Resistance Surveillance and Staffing
3. Applied Proteomics Appoints Erwin Estigarribia as Vice President, Commercial Operations
4. Synergy Health plc Invests 18 Million GBP (US$30 Million) To Expand Global Applied Sterilisation Technology Capacity
5. Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development
7. Report: Proteomics Research Market Reaches $1.6 Billion
8. Global Proteomics Market 2015-2024 - Technologies, Markets and Companies (Updated Edition)
9. Proteomics - Technologies, Markets and Companies 2014-2024
10. Report: Race for Proteomics Knowledge Spurs Investment and Partnerships
11. Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market is Expected to Grow to USD 52.3 Billion Globally by 2019: Transparency Market Research
Post Your Comments:
(Date:12/13/2018)... (PRWEB) , ... December 13, 2018 , ... ... ultrasound offering to patients. Women’s Excellence utilizes the GE Voluson E6 ultrasound ... our equipment so that we can stay at the forefront of innovation and ...
(Date:12/13/2018)... REDWOOD CITY, Calif. (PRWEB) , ... December 13, ... ... company transforming infectious disease diagnostics with genomics, announced today the results of an ... The early findings showed that the Karius® Test, a non-invasive blood test that ...
(Date:12/13/2018)... ... 2018 , ... Triple W, an innovator of connected health ... the first wearable device for urinary incontinence. DFree Professional is designed ... manage the care of patients with bladder control issues. DFree stands for “diaper-free.” ...
Breaking Medicine Technology:
(Date:12/18/2018)... (PRWEB) , ... December 18, 2018 , ... The sacroiliac ... and it is estimated that SI joint pain affects 15-25% of patients suffering from ... patients who had previously undergone lumbar fusion surgery and pregnancy related pelvic instability is ...
(Date:12/16/2018)... ... December 15, 2018 , ... Solo Printing, a Miami-based ... Missions, a local non-profit who connects communities around Latin America with access to clean ... Latin America to help improve health and the overall quality of life in rural ...
(Date:12/14/2018)... ... December 14, 2018 , ... VitalWare, ... online tool that provides a strategic and meaningful way to adhere to the ... CMS will require all hospitals to make public a list of their standard ...
(Date:12/14/2018)... CHARLOTTE, N.C. (PRWEB) , ... December 14, 2018 , ... ... the Workhorse Saddle Chair , a chair with a contoured saddle shape that ... by sitting for long periods. France launched the Workhorse Saddle chair on Kickstarter on ...
(Date:12/14/2018)... ... ... The Parenteral Drug Association (PDA) today announced the results of its Board ... 2018, PDA’s 10,500 members had an opportunity to participate in the election of new ... Board of Directors for three-year terms starting Jan. 1, 2019: , ...
Breaking Medicine News(10 mins):